Latest News

  • Molecular Medicine Tri-Conference 2018: Genetic Screening, Diagnosis, And More

    Diagnostics World | Molecular Medicine Tri-Conference will celebrate its 25th anniversary next February in San Francisco. Here are a few of the talks we’ve marked so far.

    Nov 27, 2017
  • Senator Calls For More Scrutiny Of Home DNA Test Industry

    NBC News | With the holiday season in full swing, Sen. Chuck Schumer said customers may be putting their genetic information at risk of being sold to third parties.

    Nov 27, 2017
  • Illumina Wins UK Patent Infringement Suit Against Premaitha Health, Ariosa Diagnostics

    Diagnostics World Brief | Illumina announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Premaitha Health and Ariosa Diagnostics for non-invasive prenatal tests.

    Nov 21, 2017
  • Genomenon Creates Automated, Evidence-Based Cancer Gene Panel

    Xconomy | Genomenon, a University of Michigan spinout developing analytics and data visualization software for the genomics industry, last week announced it has created an evidence-based cancer gene panel using automated machine learning techniques.

    Nov 21, 2017
  • AMP Makes Recommendations For Clinical Sequencing Labs

    Diagnostics World Brief | The Association for Molecular Pathology (AMP) published 17 consensus recommendations to help clinical laboratory professionals achieve high-quality sequencing results and deliver better patient care. The report, “Standards and Guidelines for Validating Next Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists,” was released yesterday online ahead of publication in The Journal of Molecular Diagnostics.

    Nov 17, 2017
  • Illumina Grows Clinical IVD Portfolio With Introduction Of NextSeq 550Dx, Expanded Use Of MiSeqDx

    Diagnostics World Brief | Illumina announced today the introduction of its NextSeq 550Dx instrument and the updated use of its MiSeqDx instrument, expanding Illumina’s diagnostic NGS product portfolio capable of covering a broad range of clinical applications to serve almost any clinical lab need for NGS-based in vitro diagnostic products.

    Nov 15, 2017
  • Genomics’ Role In Global Pathogen Surveillance, Diagnosis

    Diagnostics World | A recent Nature Reviews Genetics article explores the steps moving us toward a genomics-informed, real-time, global pathogen surveillance system, and the need for such progress.

    Nov 14, 2017
  • Are DNA-Based Diets the Future of Nutrition?

    Diagnostics World | A growing body of research has suggested that the same foods and beverages can affect different people in very different ways.

    Nov 13, 2017
  • Caris Life Sciences Files Patent Infringement Suits Against Foundation Medicine

    Diagnostics World News Brief | Caris Life Sciences has filed a patent infringement suit against Foundation Medicine in the United States District Court for the District of Massachusetts Boston Division. Caris is seeking damages and other relief for Foundation's willful infringement of Caris' patent rights by its FoundationOne, FoundationACT and FoundationOne Heme products.

    Nov 8, 2017
  • HudsonAlpha, Kailos Launch Third Year Of Population Screening Project

    Diagnostics World | HudsonAlpha Institute for Biotechnology announced the continuation and expansion of its Information is Power initiative today. This will be the third year HudsonAlpha and Kailos Genetics have run the initiative and the second year it is being sponsored by Redstone Federal Credit Union.

    Nov 8, 2017